News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sparring Over Trade Secrets, Dicerna (DRNA) Brings New Antitrust Suit Against Alnylam (ALNY)



8/11/2017 8:09:27 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Dicerna Pharmaceuticals has filed an antitrust lawsuit against Alnylam Pharmaceuticals, escalating a legal fight between two rival biotech companies developing a type of treatment for a series of rare metabolism disorders.

Dicerna filed the lawsuit in Boston federal court on Tuesday, accusing Alnylam of scheming to undermine Dicerna from developing metabolism disorder treatments using RNA interference (RNAi), which prevents genes from making their designated proteins.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES